STAT Plus: U.S. officials will let Novartis pay expenses for some Kymriah patients who must travel for treatment
The decision comes as the federal government is cracking down on drug companies that entice Medicare beneficiaries to use more of their medicines.
No hay comentarios:
Publicar un comentario